Endocrinology

Top Story

Grading system may predict recurrence, progression of pituitary neuroendocrine tumors

June 27, 2017

The risk for recurrence or progression of pituitary neuroendocrine tumors in adults is significantly associated with age and tumor type, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Gérald Raverot, MD, PhD, of Hospices Civils de Lyon, Federation d'Endocrinologie du Pole Est in France, and colleagues evaluated 374 adults (194 women) who underwent surgery for a pituitary neuroendocrine tumor (mean age at surgery, 51.9 years) between February 2007 and October 2012 to test the value of a new classification system on prognostic relevance.

FDA News

FDA releases plan to expedite, promote generic drug development

June 27, 2017
As part of its effort to increase competition in the prescription drug market, the FDA released a list of drugs that are off-patent and off-exclusivity without approved…

Armed with CBO report, AAFP sharply critical of Senate health care bill

June 27, 2017
AAFP has unleashed a new round of criticism in the wake of the Congressional Budget Office releasing an analysis of the Senate health care bill known as the Better Care…
In the Journals Plus

Diabetes, prediabetes prevalence high in Chinese adults

June 27, 2017
The overall prevalence of diabetes among adults in China reached nearly 11%, and prevalence of prediabetes reached nearly 36% in 2013, according to nationally…
In the Journals

Acupuncture ineffective in treating infertility

June 27, 2017
Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene did not increase live births, compared with control acupuncture…
More News Headlines »
CME CNE CPE CE

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W…
More »
Video
Meeting News

VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations

May 22, 2017
More »
Featured
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement